Articles

Results 1 to 5 of 49
Most popular |Most recent


PMPRB update: Revised compliance timelines for grandfathered and gap medicines and proposed regulatory amendments directed to CSPs

Canada - April 29 2021 On April 16, 2021, in view of COVID-19, the Patented Medicine Prices Review Board…

PMPRB Updates: Definition of “Gap Medicine” amended, modified threshold for investigating the price of new patented medicines

Canada - March 30 2021 On March 17, 2021 the Patented Medicine Prices Review Board (PMPRB) announced the result of the Consultation opened in January…

Alberta Court of Appeal dismisses Allergan’s appeal regarding interchangeability of LUMIGAN RC and VISTITAN

Canada - February 22 2021 On January 29, 2021, the Alberta Court of Appeal dismissed Allergan's appeal of a judicial review decision relating to the interchangeability of its…

PMPRB proposes to modify Guidelines definition of "gap medicine" to include medicines sold by July 1, 2021

Canada - January 26 2021 As previously reported, regulations further amending the coming into force date of the Regulations Amending the Patented Medicines Regulations…

FCA provides guidance on standard for leave to appeal interlocutory PMNOC decisions

Canada - December 17 2020 On December 3, 2020, the Federal Court of Appeal released its first decision providing guidance on the standard for obtaining leave to appeal…

Reagan Seidler.